Non Alcoholic Fatty Liver Disease: Correlation With Clinical Hormonal and Biochemical Parameters

作者: Rodoula Trigidou , Constantine Goritsas , Georgios Papatheodorou , Angeliki Ferti , Petros Garzonis

DOI: 10.2015/HC.V2I3.37

关键词:

摘要: BACKGROUND: Non alcoholic fatty liver disease (NAFLD) refers to a wide spectrum of damage, ranging from simple steatosis steatohepatitis (NASH) and cirrhosis. The aim this study was describe the variance clinical laboratory parameters that could play role in development NASH group patients with NAFLD. PATIENTS AND METHODS: Clinical, biochemical histological features 36 NAFLD were analyzed. Insulin leptin serum levels measured Body Mass Index (BMI) insulin resistance (HOMA index) calculated. same analyzed 10 healthy controls. RESULTS: Signs chronic findings advanced fibrosis detected 2 (5,5%), while hepatomegaly frequent finding (21 patients, 58,3%). confirmed 21 (58,3%).Statistically significant difference found between controls BMI (32 vs 25, p=0,002), (33,3 9,5, p=0,015) HOMA index (9,4 2,3 p=0,006). In comparing (FL) we observed similar (31,1 32) BMI, higher (42 22 p=0,044), as well (11 7,5) (22 16,6) although differences did not reach statistical significance. CONCLUSIONS: This confirms important obesity greek patients. A positive correlation is also severity damage degree resistance. I N T R O D U C an increasingly recognized condition steatohepatitis, which can progress should be differentiated resulting secondary causes such genetic disorders (lipodystrophy, dysbetalipoproteinemia, etc), nutritional (starvation, total parenteral nutrition, protein caloric malnutrition drugs (estrogens, glucocorticoids, amiodarone, valproic acid Department Internal Medicine, “SOTIRIA” Hospital, Athens, Greece Laboratory Biochemistry, 401 Pathology , “Sotiria” List οf AbbreviAtions: NAFLD: NASH: Steatohepatitis BMI: FL: Fatty HOMA: Homeostatic Model Assessment

参考文章(19)
D. Le, D. Marks, E. Lyle, C. L. Corless, B. S. Diggs, B. A. Jobe, T. Kay, C. W. Deveney, B. M. Wolfe, C. T. Roberts, R. W. O’Rourke, Serum leptin levels, hepatic leptin receptor transcription, and clinical predictors of non-alcoholic steatohepatitis in obese bariatric surgery patients Surgical Endoscopy. ,vol. 21, pp. 1593- 1599 ,(2007) , 10.1007/S00464-006-9185-5
Ender Serin, Birol �zer, Y�ksel G�m�rd�l�, Fazilet Kayasel�uk, Kemal Kul, Sedat Boyac?o?lu, Serum leptin level can be a negative marker of hepatocyte damage in nonalcoholic fatty liver. Journal of Gastroenterology. ,vol. 38, pp. 471- 476 ,(2003) , 10.1007/S00535-002-1084-5
F. Pérez-Aguilar, Etiopatogenia de la esteatohepatitis no alcohólica Gastroenterología y Hepatología. ,vol. 28, pp. 396- 406 ,(2005) , 10.1157/13077761
T Tsuji, Y Iwasaki, H Shimomura, T Ogura, T Higashi, K Matsuura, K Tobe, A Imai, C Tsukamoto, Relationship between serum leptin and fatty liver in Japanese male adolescent university students The American Journal of Gastroenterology. ,vol. 94, pp. 3328- 3335 ,(1999) , 10.1016/S0002-9270(99)00608-5
Paul Angulo, Nonalcoholic fatty liver disease. The New England Journal of Medicine. ,vol. 346, pp. 1221- 1231 ,(2002) , 10.1056/NEJMRA011775
Zobair M. Younossi, Anna Mae Diehl, Janus P. Ong, Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology. ,vol. 35, pp. 746- 752 ,(2002) , 10.1053/JHEP.2002.32483
Shivakumar Chitturi, Geoffrey Farrell, Linda Frost, Adamandia Kriketos, Rita Lin, Christopher Liddle, Dev Samarasinghe, Jacob George, Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity?☆ Hepatology. ,vol. 36, pp. 403- 409 ,(2002) , 10.1053/JHEP.2002.34738
Helen Lydatakis, Ieronymos Philippos Hager, Eyaggelia Kostadelou, Stavros Mpousmpoulas, Stavros Pappas, Ioannis Diamantis, Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease Liver International. ,vol. 26, pp. 864- 871 ,(2006) , 10.1111/J.1478-3231.2006.01312.X
Elizabeth M. Brunt, Christine G. Janney, Adrian M. Bisceglie, Brent A. Neuschwander-Tetri, Bruce R. Bacon, Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions The American Journal of Gastroenterology. ,vol. 94, pp. 2467- 2474 ,(1999) , 10.1111/J.1572-0241.1999.01377.X